Loading…

Ketamine-Assisted Group Psychotherapy for Frontline Healthcare Workers with COVID-19-Related Burnout and PTSD: A Case Series of Effectiveness/Safety for 10 Participants

This study reports on 10 frontline healthcare workers, employed during the COVID-19 pandemic and experiencing symptoms of burnout and PTSD, treated with group ketamine-assisted psychotherapy (KAP) in a private outpatient clinic setting. Participants attended 6 sessions once weekly. These included 1...

Full description

Saved in:
Bibliographic Details
Published in:Journal of psychoactive drugs 2024-01, Vol.56 (1), p.1-32
Main Authors: Robison, Reid, Brendle, Madeline, Moore, Claire, Cross, Hannah, Helm, Lindsay, Darling, Shannon, Thayer, Stephen, Thielking, Paul, Shannon, Scott
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c370t-f53a81a92e2b79751014106e27266ccb03d01b04fa29def26854ca22ad7fb9823
cites cdi_FETCH-LOGICAL-c370t-f53a81a92e2b79751014106e27266ccb03d01b04fa29def26854ca22ad7fb9823
container_end_page 32
container_issue 1
container_start_page 1
container_title Journal of psychoactive drugs
container_volume 56
creator Robison, Reid
Brendle, Madeline
Moore, Claire
Cross, Hannah
Helm, Lindsay
Darling, Shannon
Thayer, Stephen
Thielking, Paul
Shannon, Scott
description This study reports on 10 frontline healthcare workers, employed during the COVID-19 pandemic and experiencing symptoms of burnout and PTSD, treated with group ketamine-assisted psychotherapy (KAP) in a private outpatient clinic setting. Participants attended 6 sessions once weekly. These included 1 preparation session, 3 ketamine sessions (2 sublingual, 1 intramuscular), 2 integration sessions. Measures of PTSD (PCL-5), depression (PHQ-9), and anxiety (GAD-7) were administered at baseline and post-treatment. During ketamine sessions, the Emotional Breakthrough Inventory (EBI) and the 30-item Mystical Experience Questionnaire (MEQ-30) were recorded. Participant feedback was gathered 1-month post-treatment. We observed improvements in participants' average PCL-5 (59% reduction), PHQ-9 (58% reduction), and GAD-7 (36% reduction) scores from pre- to post-treatment. At post-treatment, 100% of participants screened negative for PTSD, 90% had minimal/mild depression or clinically significant improvement, and 60% had minimal/mild anxiety or clinically significant improvement. MEQ and EBI scores had large variations among participants at each ketamine session. Ketamine was well tolerated, and no significant adverse events were reported. Participant feedback corroborated findings of improvements observed in mental health symptoms. We found immediate improvements treating 10 frontline healthcare workers experiencing burnout, PTSD, depression, and anxiety using weekly group KAP and integration.
doi_str_mv 10.1080/02791072.2023.2186285
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2783493452</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2942021095</sourcerecordid><originalsourceid>FETCH-LOGICAL-c370t-f53a81a92e2b79751014106e27266ccb03d01b04fa29def26854ca22ad7fb9823</originalsourceid><addsrcrecordid>eNpdkU1v1DAQhi0Eape2PwFkiQuXbO1xEsfclu2nqNRVt4Vj5DhjbUo2DrYD2n_EzyTRbjn0NJfnfWdGDyEfOJtzVrBzBlJxJmEODMQceJFDkb0hM-CZSpSU8i2ZTUwyQcfkfQjPjLEc8vyIHIt8wkHNyN9vGPW26TBZhNCEiDW99m7o6SrszMbFDXrd76h1nl5518V2ROkN6jZujPZIfzj_E32gf5q4ocv777cXCVfJA7Z6qvo6-M4NkequpqvH9cUXuqBLHZCu0TcYqLP00lo0sfmNHYZwvtYW434dZ3SlfWxM0-suhlPyzuo24NlhnpCnq8vH5U1yd399u1zcJUZIFhObCV1wrQChkkpmnPGUsxxBjp8bUzFRM16x1GpQNVrIiyw1GkDX0laqAHFCPu97e-9-DRhiuW2CwbbVHbohlCALkSqRZhP66RX67MaHx-tKUOnohTOVjVS2p4x3IXi0Ze-brfa7krNyUlm-qCwnleVB5Zj7eGgfqi3W_1Mv7sQ_WhOZCw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2942021095</pqid></control><display><type>article</type><title>Ketamine-Assisted Group Psychotherapy for Frontline Healthcare Workers with COVID-19-Related Burnout and PTSD: A Case Series of Effectiveness/Safety for 10 Participants</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Robison, Reid ; Brendle, Madeline ; Moore, Claire ; Cross, Hannah ; Helm, Lindsay ; Darling, Shannon ; Thayer, Stephen ; Thielking, Paul ; Shannon, Scott</creator><creatorcontrib>Robison, Reid ; Brendle, Madeline ; Moore, Claire ; Cross, Hannah ; Helm, Lindsay ; Darling, Shannon ; Thayer, Stephen ; Thielking, Paul ; Shannon, Scott</creatorcontrib><description>This study reports on 10 frontline healthcare workers, employed during the COVID-19 pandemic and experiencing symptoms of burnout and PTSD, treated with group ketamine-assisted psychotherapy (KAP) in a private outpatient clinic setting. Participants attended 6 sessions once weekly. These included 1 preparation session, 3 ketamine sessions (2 sublingual, 1 intramuscular), 2 integration sessions. Measures of PTSD (PCL-5), depression (PHQ-9), and anxiety (GAD-7) were administered at baseline and post-treatment. During ketamine sessions, the Emotional Breakthrough Inventory (EBI) and the 30-item Mystical Experience Questionnaire (MEQ-30) were recorded. Participant feedback was gathered 1-month post-treatment. We observed improvements in participants' average PCL-5 (59% reduction), PHQ-9 (58% reduction), and GAD-7 (36% reduction) scores from pre- to post-treatment. At post-treatment, 100% of participants screened negative for PTSD, 90% had minimal/mild depression or clinically significant improvement, and 60% had minimal/mild anxiety or clinically significant improvement. MEQ and EBI scores had large variations among participants at each ketamine session. Ketamine was well tolerated, and no significant adverse events were reported. Participant feedback corroborated findings of improvements observed in mental health symptoms. We found immediate improvements treating 10 frontline healthcare workers experiencing burnout, PTSD, depression, and anxiety using weekly group KAP and integration.</description><identifier>ISSN: 0279-1072</identifier><identifier>EISSN: 2159-9777</identifier><identifier>DOI: 10.1080/02791072.2023.2186285</identifier><identifier>PMID: 36862829</identifier><language>eng</language><publisher>United States: Haight Ashbury Publications</publisher><subject>Anxiety ; Burnout ; Clinical significance ; COVID-19 ; Ketamine ; Medical personnel ; Mental depression ; Post traumatic stress disorder ; Psychotherapy</subject><ispartof>Journal of psychoactive drugs, 2024-01, Vol.56 (1), p.1-32</ispartof><rights>2023 Taylor &amp; Francis Group, LLC</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c370t-f53a81a92e2b79751014106e27266ccb03d01b04fa29def26854ca22ad7fb9823</citedby><cites>FETCH-LOGICAL-c370t-f53a81a92e2b79751014106e27266ccb03d01b04fa29def26854ca22ad7fb9823</cites><orcidid>0000-0003-0692-3706</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36862829$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Robison, Reid</creatorcontrib><creatorcontrib>Brendle, Madeline</creatorcontrib><creatorcontrib>Moore, Claire</creatorcontrib><creatorcontrib>Cross, Hannah</creatorcontrib><creatorcontrib>Helm, Lindsay</creatorcontrib><creatorcontrib>Darling, Shannon</creatorcontrib><creatorcontrib>Thayer, Stephen</creatorcontrib><creatorcontrib>Thielking, Paul</creatorcontrib><creatorcontrib>Shannon, Scott</creatorcontrib><title>Ketamine-Assisted Group Psychotherapy for Frontline Healthcare Workers with COVID-19-Related Burnout and PTSD: A Case Series of Effectiveness/Safety for 10 Participants</title><title>Journal of psychoactive drugs</title><addtitle>J Psychoactive Drugs</addtitle><description>This study reports on 10 frontline healthcare workers, employed during the COVID-19 pandemic and experiencing symptoms of burnout and PTSD, treated with group ketamine-assisted psychotherapy (KAP) in a private outpatient clinic setting. Participants attended 6 sessions once weekly. These included 1 preparation session, 3 ketamine sessions (2 sublingual, 1 intramuscular), 2 integration sessions. Measures of PTSD (PCL-5), depression (PHQ-9), and anxiety (GAD-7) were administered at baseline and post-treatment. During ketamine sessions, the Emotional Breakthrough Inventory (EBI) and the 30-item Mystical Experience Questionnaire (MEQ-30) were recorded. Participant feedback was gathered 1-month post-treatment. We observed improvements in participants' average PCL-5 (59% reduction), PHQ-9 (58% reduction), and GAD-7 (36% reduction) scores from pre- to post-treatment. At post-treatment, 100% of participants screened negative for PTSD, 90% had minimal/mild depression or clinically significant improvement, and 60% had minimal/mild anxiety or clinically significant improvement. MEQ and EBI scores had large variations among participants at each ketamine session. Ketamine was well tolerated, and no significant adverse events were reported. Participant feedback corroborated findings of improvements observed in mental health symptoms. We found immediate improvements treating 10 frontline healthcare workers experiencing burnout, PTSD, depression, and anxiety using weekly group KAP and integration.</description><subject>Anxiety</subject><subject>Burnout</subject><subject>Clinical significance</subject><subject>COVID-19</subject><subject>Ketamine</subject><subject>Medical personnel</subject><subject>Mental depression</subject><subject>Post traumatic stress disorder</subject><subject>Psychotherapy</subject><issn>0279-1072</issn><issn>2159-9777</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpdkU1v1DAQhi0Eape2PwFkiQuXbO1xEsfclu2nqNRVt4Vj5DhjbUo2DrYD2n_EzyTRbjn0NJfnfWdGDyEfOJtzVrBzBlJxJmEODMQceJFDkb0hM-CZSpSU8i2ZTUwyQcfkfQjPjLEc8vyIHIt8wkHNyN9vGPW26TBZhNCEiDW99m7o6SrszMbFDXrd76h1nl5518V2ROkN6jZujPZIfzj_E32gf5q4ocv777cXCVfJA7Z6qvo6-M4NkequpqvH9cUXuqBLHZCu0TcYqLP00lo0sfmNHYZwvtYW434dZ3SlfWxM0-suhlPyzuo24NlhnpCnq8vH5U1yd399u1zcJUZIFhObCV1wrQChkkpmnPGUsxxBjp8bUzFRM16x1GpQNVrIiyw1GkDX0laqAHFCPu97e-9-DRhiuW2CwbbVHbohlCALkSqRZhP66RX67MaHx-tKUOnohTOVjVS2p4x3IXi0Ze-brfa7krNyUlm-qCwnleVB5Zj7eGgfqi3W_1Mv7sQ_WhOZCw</recordid><startdate>20240101</startdate><enddate>20240101</enddate><creator>Robison, Reid</creator><creator>Brendle, Madeline</creator><creator>Moore, Claire</creator><creator>Cross, Hannah</creator><creator>Helm, Lindsay</creator><creator>Darling, Shannon</creator><creator>Thayer, Stephen</creator><creator>Thielking, Paul</creator><creator>Shannon, Scott</creator><general>Haight Ashbury Publications</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K7.</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0692-3706</orcidid></search><sort><creationdate>20240101</creationdate><title>Ketamine-Assisted Group Psychotherapy for Frontline Healthcare Workers with COVID-19-Related Burnout and PTSD: A Case Series of Effectiveness/Safety for 10 Participants</title><author>Robison, Reid ; Brendle, Madeline ; Moore, Claire ; Cross, Hannah ; Helm, Lindsay ; Darling, Shannon ; Thayer, Stephen ; Thielking, Paul ; Shannon, Scott</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c370t-f53a81a92e2b79751014106e27266ccb03d01b04fa29def26854ca22ad7fb9823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Anxiety</topic><topic>Burnout</topic><topic>Clinical significance</topic><topic>COVID-19</topic><topic>Ketamine</topic><topic>Medical personnel</topic><topic>Mental depression</topic><topic>Post traumatic stress disorder</topic><topic>Psychotherapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Robison, Reid</creatorcontrib><creatorcontrib>Brendle, Madeline</creatorcontrib><creatorcontrib>Moore, Claire</creatorcontrib><creatorcontrib>Cross, Hannah</creatorcontrib><creatorcontrib>Helm, Lindsay</creatorcontrib><creatorcontrib>Darling, Shannon</creatorcontrib><creatorcontrib>Thayer, Stephen</creatorcontrib><creatorcontrib>Thielking, Paul</creatorcontrib><creatorcontrib>Shannon, Scott</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Criminal Justice (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of psychoactive drugs</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Robison, Reid</au><au>Brendle, Madeline</au><au>Moore, Claire</au><au>Cross, Hannah</au><au>Helm, Lindsay</au><au>Darling, Shannon</au><au>Thayer, Stephen</au><au>Thielking, Paul</au><au>Shannon, Scott</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ketamine-Assisted Group Psychotherapy for Frontline Healthcare Workers with COVID-19-Related Burnout and PTSD: A Case Series of Effectiveness/Safety for 10 Participants</atitle><jtitle>Journal of psychoactive drugs</jtitle><addtitle>J Psychoactive Drugs</addtitle><date>2024-01-01</date><risdate>2024</risdate><volume>56</volume><issue>1</issue><spage>1</spage><epage>32</epage><pages>1-32</pages><issn>0279-1072</issn><eissn>2159-9777</eissn><abstract>This study reports on 10 frontline healthcare workers, employed during the COVID-19 pandemic and experiencing symptoms of burnout and PTSD, treated with group ketamine-assisted psychotherapy (KAP) in a private outpatient clinic setting. Participants attended 6 sessions once weekly. These included 1 preparation session, 3 ketamine sessions (2 sublingual, 1 intramuscular), 2 integration sessions. Measures of PTSD (PCL-5), depression (PHQ-9), and anxiety (GAD-7) were administered at baseline and post-treatment. During ketamine sessions, the Emotional Breakthrough Inventory (EBI) and the 30-item Mystical Experience Questionnaire (MEQ-30) were recorded. Participant feedback was gathered 1-month post-treatment. We observed improvements in participants' average PCL-5 (59% reduction), PHQ-9 (58% reduction), and GAD-7 (36% reduction) scores from pre- to post-treatment. At post-treatment, 100% of participants screened negative for PTSD, 90% had minimal/mild depression or clinically significant improvement, and 60% had minimal/mild anxiety or clinically significant improvement. MEQ and EBI scores had large variations among participants at each ketamine session. Ketamine was well tolerated, and no significant adverse events were reported. Participant feedback corroborated findings of improvements observed in mental health symptoms. We found immediate improvements treating 10 frontline healthcare workers experiencing burnout, PTSD, depression, and anxiety using weekly group KAP and integration.</abstract><cop>United States</cop><pub>Haight Ashbury Publications</pub><pmid>36862829</pmid><doi>10.1080/02791072.2023.2186285</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0003-0692-3706</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0279-1072
ispartof Journal of psychoactive drugs, 2024-01, Vol.56 (1), p.1-32
issn 0279-1072
2159-9777
language eng
recordid cdi_proquest_miscellaneous_2783493452
source Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)
subjects Anxiety
Burnout
Clinical significance
COVID-19
Ketamine
Medical personnel
Mental depression
Post traumatic stress disorder
Psychotherapy
title Ketamine-Assisted Group Psychotherapy for Frontline Healthcare Workers with COVID-19-Related Burnout and PTSD: A Case Series of Effectiveness/Safety for 10 Participants
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T13%3A52%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ketamine-Assisted%20Group%20Psychotherapy%20for%20Frontline%20Healthcare%20Workers%20with%20COVID-19-Related%20Burnout%20and%20PTSD:%20A%20Case%20Series%20of%20Effectiveness/Safety%20for%2010%20Participants&rft.jtitle=Journal%20of%20psychoactive%20drugs&rft.au=Robison,%20Reid&rft.date=2024-01-01&rft.volume=56&rft.issue=1&rft.spage=1&rft.epage=32&rft.pages=1-32&rft.issn=0279-1072&rft.eissn=2159-9777&rft_id=info:doi/10.1080/02791072.2023.2186285&rft_dat=%3Cproquest_cross%3E2942021095%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c370t-f53a81a92e2b79751014106e27266ccb03d01b04fa29def26854ca22ad7fb9823%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2942021095&rft_id=info:pmid/36862829&rfr_iscdi=true